Back | Next |
home / stock / vstm / vstm message board
Subject | By | Source | When |
---|---|---|---|
whytestocks: $VSTM News Article - Verastem $VSTM Proactive Strategies | whytestocks | investorshangout | 03/13/2023 2:15:49 PM |
2 million volume yesterday. Thats a fund imo. | Harbor6460 | investorshub | 02/03/2023 5:51:45 PM |
In addition to the progress with avutometinib + | Tartiaboy | investorshub | 01/29/2023 6:00:49 PM |
The RAMP201 and FRAME data for LGSOC is | Tartiaboy | investorshub | 01/26/2023 3:25:06 PM |
I think that anyone interested needs to follow-up | Tartiaboy | investorshub | 01/25/2023 6:39:25 PM |
Regulatory Update Following Type B FDA Meeting on | DrHarleyboy | investorshub | 01/25/2023 6:33:02 PM |
I already one a nice chunk. Listened | Tartiaboy | investorshub | 01/25/2023 6:26:16 PM |
Ramp 201 Data Updated, and a Private Placement secured. | DrHarleyboy | investorshub | 01/25/2023 6:10:40 PM |
Looks like Big mews coming in next 3-6 months | Harbor6460 | investorshub | 01/18/2023 10:37:11 PM |
Well, not time like the present to start | DrHarleyboy | investorshub | 12/21/2022 1:42:36 PM |
znewcar1: $VSTM 9% v619K c.45 f210,1M H.45 ML3.41 | znewcar1 | investorshangout | 12/10/2022 3:47:37 AM |
Nobody posts. But i know its coming. Boommmmmmm | Harbor6460 | investorshub | 12/07/2022 7:17:11 PM |
znewcar1: $VSTM 13% v984K c.46 f210M H.4656 ML.361 | znewcar1 | investorshangout | 11/30/2022 11:52:32 PM |
znewcar1: $VSTM 25% v4,2M c.3801 f210M H.3875 ML.2895 or afthoursL.2822 | znewcar1 | investorshangout | 10/25/2022 9:48:27 PM |
I thinkthis is a HR. 90 mil cash. | Harbor6460 | investorshub | 10/21/2022 6:52:23 PM |
I imagine hedge funds are unloading their losses | DrHarleyboy | investorshub | 10/19/2022 3:40:08 PM |
What is going on here | Harbor6460 | investorshub | 10/19/2022 3:29:16 PM |
znewcar1: LOD.38= ML=LL $VSTM | znewcar1 | investorshangout | 10/14/2022 4:25:45 PM |
People can sell.I keep buying. I been following | Harbor6460 | investorshub | 08/15/2022 5:34:01 PM |
znewcar1: VSTM 5% v4,8M c1.27 f187M | znewcar1 | investorshangout | 08/15/2022 4:04:53 AM |
News, Short Squeeze, Breakout and More Instantly...
GenFleet’s IND in China was cleared in June 2024; this is the first discovery program from the collaboration Verastem announced in 2023 to advance into human clinical trials Verastem plans to initiate development studies outside of China after evaluating initial dose escalation dat...
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that in connection with the 2024 Russell U.S. Indexes annual reconstitution, the company will be added to the Russell 3000 ® and Russell Microcap ...
2024-06-12 09:44:18 ET USA News Group Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 12, 2024 – USA News Group – After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovere...